Products & Services · Cost of Sales
Other — Cost of Sales
United Therapeutics Other — Cost of Sales decreased by 13.6% to $12.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 101.7%, from $6.00M to $12.10M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue suggests declining margins or operational inefficiencies in the segment, while a decrease may indicate improved cost management or reduced activity levels.
Detailed definition
This metric measures the direct costs associated with producing or delivering the goods and services within the company'...
Peer comparison
Comparable to 'Cost of Goods Sold' for non-core segments in other pharmaceutical or biotech firms, often reflecting R&D-heavy or early-stage commercialization costs.
Metric ID:
uthr_segment_other_cost_of_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.80M | $3.10M | $4.90M | $4.20M | $6.10M | $7.40M | $6.70M | $5.80M | $7.00M | $6.00M | $7.00M | $11.00M | $14.00M | $12.10M |
| QoQ Change | — | — | — | — | — | — | — | -71.3% | +58.1% | -14.3% | +45.2% | +21.3% | -9.5% | -13.4% | +20.7% | -14.3% | +16.7% | +57.1% | +27.3% | -13.6% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -43.5% | +138.7% | +36.7% | +38.1% | +14.8% | -18.9% | +4.5% | +89.7% | +100.0% | +101.7% |
Range$0.00 – $14.00M
Avg YoY Growth+46.2%
Median YoY Growth+37.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's other — cost of sales?
- United Therapeutics (UTHR) reported other — cost of sales of $12.10M in Q1 2026.
- How has United Therapeutics's other — cost of sales changed year-over-year?
- United Therapeutics's other — cost of sales increased by 101.7% year-over-year, from $6.00M to $12.10M.
- What does other — cost of sales mean?
- The direct costs incurred to produce the products or services sold within the company's secondary business segments.